Speakers

Friedrich Graf Finckenstein

Chief Medical Officer • Iovance Biotherapeutics Inc

Dr. Graf Finckenstein joined Iovance in July 2019. He is a physician-scientist with decades of experience in clinical medicine, laboratory cancer research and drug development in the biopharmaceutical industry. Prior to joining Iovance he was the Global Head of Oncology Translational Medicine at Roche Pharma Research and Early Development (pRED) in Basel, Switzerland, where he led all clinical development aspects in the Oncology Discovery and Translational area, including the design and conduct of clinical trials, exploratory development studies and translational medicine, biomarker and personalized healthcare strategy. Earlier, Dr. Graf Finckenstein held multiple clinical leadership roles at Bristol-Myers Squibb, where he worked on an array of products from early clinical development to late stage, including key contributions to the approval of Opdivo® in lung cancer. Dr. Graf Finckenstein has a medical degree from the University of Hamburg in Germany. He holds a German medical license, a pediatric board certification, and has conducted basic cancer research at the Ludwig Institute, San Diego Branch, the Children’s Hospital Los Angeles and the University of Hamburg.

Also Speaking

Scott Gottesman

Vice President, Human Resources • AVROBIO

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies  • Novartis

Julie Lenzer

Chief Innovation Officer • ARMI | BioFabUSA

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Roel Gordijn

Chief Commercial Officer • Polyplus

Roel Gordijn is Chief Commercial Officer at Polyplus®. In this role he manages global, sales, marketing, and scientific support teams.

Before joining Polyplus in 2021, Roel was General Manager of Gene-Therapy business at Pall Biotech. He previously held several senior management roles at Pall/Danaher, and Lonza, as Global director of Industrial Cell Culture Media Sales and Marketing.

Also Speaking

Thomas Bollenbach

Chief Technology Officer • ARMI

Jason B. Litten

Chief Medical Officer • Chimeric Therapeutics

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

 

 

Also Speaking

Sean McAuliffe

Chief Commercial Officer • Taysha Gene Therapies

Shreenal Patel

Executive Vice President, Patient Supply • Achilles Therapeutics

Cynthia Pussinen

Chief Technical Officer • Spark Therapeutics

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Pete Robinson

Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos

Also Speaking

Pierre Boulas

Head of Medical Devices and Packaging Development • Biogen

Alex Dahmani

Director of Business Development • Adaptive Biotechnologies

Joanne Brewer

Chief Scientific Officer • AdaptImmune

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Michael Lawlor

Professor • Medical College of Wisconsin

Dr. Lawlor is a neuropathologist and neuroscientist who joined MCW’s faculty in 2011. He has served as the Associate Director of the Neuroscience Research Center since 2017. Dr. Lawlor directs two clinical laboratories that process and diagnose muscle and nerve biopsies. His research laboratory includes both traditional grant funding and extensive industry collaborations on congenital myopathy, muscular dystrophy, mitochondrial disease and gene therapy.

Also Speaking

Timothy D. Hunt

Chief Executive Officer • Alliance for Regenerative Medicine

Faraz Ali

Chief Executive Officer • Tenaya Therapeutics

Teonna Woolford

Chief Executive Officer • Sickle Cell Reproductive Health Education Directive

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Brahm Goldstein

Vice President, Research and Development, Hematology • CSL Behring

Also Speaking

Jason B. Litten

Chief Medical Officer • Chimeric Therapeutics

Matthew Lakelin

Co-Founder, Vice President of Scientific Affairs & Product Development • TrakCel

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Zhimei Du

Vice President, Translational Research and Early Development • Landmark Bio

Dr. Zhimei Du is a leader in the fields of Cell/Gene Therapy and Biologics with significant experience in both early and late-stage development. She serves as Vice President at Landmark Bio leading the Translational Research and Early Development of next-generation cell/gene therapies for various diseases. Prior to joining Landmark Bio, Dr. Du was at Atara Biotherapeutics, as Vice President focusing on accelerating both early and late-stage cell therapy pipelines. Prior to that, she was at Merck & Co. as the Executive Director & Global Head of Process Cell Sciences. In this role, Dr. Du established various new core functions in cell therapy and biologics during early development. She has also been active in successful business development activities, including evaluating and building partnerships for CAR-T and CAR-NK programs. Dr. Du holds numerous patents and publications in cell and gene therapy, protein engineering, cell engineering, vector engineering, molecular mechanisms in autoimmune disease and cancer immunity, process optimization, and genetic/epigenetic biomarker development.

Dr. Du received her Ph.D. in Immunology from Cornell University Medical College. She was a Postdoctoral Fellow at Robert G. Roeder’s laboratory, Rockefeller University, where she focused on the discovery of genetic/epigenetic regulation mechanisms during leukemia genesis.

Also Speaking

Jian Irish

President and Chief Operating Officer • Metagenomi

Andrew Olaye

Executive Director, Market Access & Partnerships EMEA • Orchard Therapeutics

Lili Belcastro

Senior Principal Scientist, Cell and Gene Therapy Raw Materials • Bristol Myers Squibb

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Gregg Nyberg

Chief Technology Officer • Landmark Bio

Gregg Nyberg, Ph.D., brings more than 20 years’ biopharmaceutical industry experience to his new role at Landmark Bio. Most recently, he was associate vice president at Merck, where he led the company’s biologics process development and clinical manufacturing organizations. He also spent nearly 15 years in positions of increasing responsibility at Amgen including key leadership roles in process development and cell sciences and technology.

Dr. Nyberg earned a Ph.D. in chemical engineering from the Massachusetts Institute of Technology and a B.S. in chemical engineering and petroleum refining from the Colorado School of Mines.

Also Speaking

Fran Gullo

Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics

Tay Salimullah

Vice President, Head of Global Value & Access, Novartis Gene Therapies  • Novartis

J Kelly Ganjei

President and Chief Executive Officer • AmplifyBio

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Wolfgang Künnecke

Vice President of Bioanalytics • 908 Devices

Wolfgang Künnecke is the Vice President of Bioanalytics at 908 Devices. He founded and served as CEO of TRACE Analytics, the first manufacturer in the world to offer a continuous enzymatic based monitoring of bioreactors, until it was acquired by 908 Devices in August 2022. Wolfgang has more than 25 years of experience in online monitoring of bioprocesses, specializing in biosensors that offer continuous measurement of glucose and lactate. He holds a Ph.D in biotechnology and biosensors from the German Research Centre for Biotechnology (now the Helmholtz Centre for Infection Research) in Braunschweig, Germany.

Also Speaking

Lior Raviv

Chief Technical Officer • Pluri

Joanne Brewer

Chief Scientific Officer • AdaptImmune

Fran Gullo

Scientific Director, Gift of Life Center for Cell and Gene Therapy • Gift of Life Biologics

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.
Speakers

Mark Sawicki

President & Chief Executive Officer • Cryoport Systems

Mark Sawicki brings over 15 years of business development and sales management experience, having consistently delivered on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Sawicki was most recently the chief business officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. Additionally, he has served in senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI), where he increased revenue at rates far outpacing industry standards. Sawicki holds a bachelor’s in biochemistry from the State University of New York at Buffalo and a Ph.D. in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute. Sawicki has authored a dozen scientific publications in drug discovery with a focus on oncology and immunology.

Also Speaking

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Rebecca Lim

Senior Vice President – Scientific Affairs • Prescient Therapeutics

Cynthia Pussinen

Chief Technical Officer • Spark Therapeutics

Also Speaking

Image

Germfree Truck

Image

Hotels

Book your hotel room for your stay in Miami.